Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
somehow with your posts, I never can make it further than the first sentence where the BS is already pilehigh. Complete and other rubbish
are you really that dumb. I guess you are
we need whales to buy in and NWBO to stop diluting the living crap out of the stock. The formal isn't gonna happen at the OTC and the latter is not going to happen with Linda Powers refusing to make a non-dilutive deal to finance Advent a Toucan subsidiary with (for example) a private equity partner. With a private equity partner Linda Powers and Toucan would have to, God forbid, give up on a small portion of Advent. So they rather keep diluting us to finance Advent in an illegitimate manner.
If you coherently rephase yourself I may reply, right now I have no freaking clue what the heck you are rambling about
agreed yes to each their own. The problem that I do have with these stratosphere fantasy speculations that is food for bears and shorts
The idea that Merck is investing in production capacity now for a future deal that they may or may not enter in with NWBO in the future to produce DCVAX(L) without actually having entered into a deal with NWBO (which would be material and should have been disclosed) is ludicrous. These kinds of absurd claims (also the NWBO Apple valuation) will only help bears and shorts to ridicule longs as they have done with great success here.
since you are already scaling back from your previous bet (and as I recall that is not the first time you are doing that) by now setting the date to Aug 1 this year instead of all of 2024 as you said you would in your Dec 18 2023 post (Thank you Stonk for finding that post), why should anyone trust you you will come not back at your words? When (not if) DCVAXL L is approved by the MHRA in (Q3) 2024 you will then say you never made any of such bet and ignore your own quoted words as you always do, so tell me why would anyone make that bet with you now?
Anyway, the bet is, since you already agreed upon the terms, no approval in 2024 and at least I will disappear from this board, and if approved in 2024 then you will leave this board.
I will donate $500K to any nonprofit goodwill project of your choosing if within 6 months after UK approval NWBO's market cap reaches a $45 billion or more valuation.
Good lord, please stop it with the Apple comparison. it borders to insanity
yes he made it up, his valuation is as nuts as your valuation now and after UK approval. So you are both kuku
please explain to me this then. As of Jan 1 2024, the MHRA has put in place a new 150 days +60 days clock stop = 210 days review process in place FOR NEVER approved drugs (if already EMA or FDA approved then the time span is actually within 60 days review)
hahahaha you state one BS post after another with claims that have no connection with reality let alone with any source and now you have the audacity to demand sources from me. You will first provide evidence that NWBO is only going to make about $10,000 - $15,000 per case as you claim. And then I will provide evidence. Nutcase
No Im not arguing with you. Im saying its within 150 days after valid submission (which was probably) from Dec 21st. If you are saying the same thing then we agree. I seriously thought you were saying from the moment the application has been accepted.
Sorry for any confusion
Good grief
- The UK will allocate around $ 450 million for treating GBM
- Every patient can afford it through their healthcare insurance. Where are you from Bangladesh? Then stay in India numb nut
- NWBO SP has declined yes. And after UK approval it wil x5 at least
- The patents are not outdated you just made that up again liar. Also even IF biotech patents are outdated then still for other big pharma te conduct similar trials would take many years.
- Every non biotech is undergoing dilution dumbo
Sop with the f@cking lies asswhipe
ooh come one the MHRA is saying marketing authorisation and reach its opinion on approvability within 150 days of submission of a valid application. The UK government website is saying it.
Many other reliable sources are saying it. Case closed seriously
ok so you are looking for this then:
https://www.gov.uk/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines
you mean this:
no you are being delusional denying the reality that the MHRA will approve DCVAXL and DCVAXL with all patents and IP is owned by NWBO. After that its very likely the FDA and EMA will follow into approving of DCVAXL
I agree the funding of privately owned CDMO through NWBO by Linda is a grift
yes that turned about to be a nothing burger
yes yes yes the hedgies. Again if you think that more investors want to (short) sell NWBO at Nasdaq than there are institutions that want to buy (banks/ bio tech equity fund and let's not forget retail that have at present no OTC access) then you should sell today.
Another reason you should sell today: You think NWBO after UK approval is the same NWBO when they were demoted to the OTC in 2017
Are you a short?
Learn to count. lets say you own 1000 NWBO shares reverse split 1:5 at $2 after UK approval so you own $2000 in NWBO after UK approval
R/S to $10 uplist. Now institutions and bio tech equity funds can and will start buying in x5 SP goes to $50 now you own $10,000 in NWBO. And $10,000 is MORE than $ 2000
And since these institutions will hold a very large portion translated into immense volume your obsessed shorts will not be able to bring the SP down again.
What is even better is that NWBO can now be bought by Merck. And if you don't believe that then at least can start financing new trials in a nontoxic manner as they do now at OTC
You:
Really? yes Really oohw now I understand.
I think Les was telling the truth when he said there are dozens of patients. I believe he just does not care that these patients are paying Advent
no on the Nasdaq institutions will be more than happy to buy into NWBO after, as I said UK approval, soaring the SP x5 at least
If you dont believe that then I suggest you sell NWBO asap
Your problem is that you have conditioned yourself to only believe in shorts, hedgies, bears. That is what your posts (on Twitter) are all bout all day (dont you have a day job?). Playing the victim, exhausting.
you remind me of Don Quichot fighting ghost windmills and not in a good way
I never said that there is not going to be a combo trial deal. First, second I dont know if the appointing of Liau to NWBO BOD has anything to do with any deal. Neither do you. The point Im making is that negotiating a combo trial deal is not a mathematical formula as Flipper suggests.
Its like arguing with a 5-year-old isnt it. She said so she said so she promised Disney land boehoe she promised she promised.
you sound like a toddler now. Linda said that when its cemented then we should have a combo trial deal. Good grief. Doing business, and making deals does not work like that. Linda Powers is not a Goddess not everything you think she said or she think said will work out the way you expect it to be. Haven't you learned that from 15 years of NWBO?
The truth of the matter is that, and thats where Flipper's mathematical approach to conducting business is incomprehensible at least in the sense that it is clear that he has very little experience in making deals, is that it is clear they have been in discussions with big pharma over a combo trial deal and its up to big pharma, not NWBO, whether that deal will see the day of light. Flipper's mistake is that he thinks that making deals of that size is a line of computer code. If the MAA has been "cemented" (when or whatever that is), then the combo trial deal with a huge amount of money for NWBO. That's just absolute nonsense.
If we are anything near a deal then NWBO's CTO Bosch would move back to the US and a certified CFO would be hired to manage the funds. We are not anywhere near a combo trail deal.